Sterol regulatory element-binding proteins: Master regulators of lipid metabolic reprogramming in cancer and emerging therapeutic targets (Review)

Qing Liu, Rui Wang, Zhenbo Li, Yihan Liu, Lei Wu, Yuqin Zhao, Jing Yang · 2026

Read Sterol regulatory element-binding proteins: Master regulators of lipid metabolic reprogramming in cancer and emerging therapeutic targets (Review) by Qing Liu, Rui Wang, Zhenbo Li, Yihan Liu, Lei Wu, Yuqin Zhao, Jing Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13280530.txt.

Description

Qing Liu and colleagues published a 2026 review of SREBPs, a family of transcription factors that act as master switches for fat and cholesterol production in cells. Tumors lean on these switches to build membranes and signaling molecules for growth. Abnormal SREBP activation shows up across cancers. The review notes the family's reach into obesity, atherosclerosis, diabetes, and neurodegenerative disease. That reach makes its regulation a medical concern.

The authors explain how the proteins sit inactive in a membrane until cleavage frees them. They then enter the nucleus and switch on genes for cholesterol, fatty acid, and triglyceride synthesis or uptake. The authors map how tumors hijack that machinery and how activation pushes malignant progression, and which drug strategies aim at the pathway. Their verdict is that blocking SREBP activity is a promising anticancer direction. The regulatory networks are intricate, and need fuller mapping before treatments can exploit them.

Catalog record

CREATORQing Liu, Rui Wang, Zhenbo Li, Yihan Liu, Lei Wu, Yuqin Zhao, Jing Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE93 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13280530

Browse the full library · About the Tower of Babel